A Study on the Correlation Between Tarceva (Erlotinib) - Induced Rash and Efficacy in EGFR Mutated Participants With Advanced Non-Small Cell Lung Cancer Receiving First-Line Therapy

Ziv Medical Center; Oncology Department, Sefad

Poria Hospital; Oncology, Tiberias

Haemek Hospital; Oncology, Afula

Nahariya Hospital; Oncology, Nahariya

Carmel Hospital; Oncology Unit, Haifa

Wolfson Hospital; Oncology, Holon

Barzilai; Oncology, Ashkelon

Shaare Zedek Medical Center; Oncology Dept, Jerusalem

Rambam Medical Center; Oncology, Haifa

Meir Medical Center; Oncology, Kfar Saba

Chaim Sheba Medical Center; Oncology Dept, Ramat Gan

Assaf Harofeh; Oncology, Ẕerifin

Kaplan Medical Center; Oncology Inst., Rehovot

Soroka Medical Center; Oncology Dept, Beersheba

Hadassah Ein Karem Hospital; Oncology Dept, Jerusalem

Sourasky / Ichilov Hospital; Oncology Department, Tel Aviv